Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
covid-19_public_health_policy:contact_tracing [2021/12/27 17:38]
robert | covid-19_public_health_policy:contact_tracing [2022/03/07 04:21] (current)
liam |
|---|
| ====== Contact Tracing ====== | ====== Contact Tracing ====== |
| | |
| | ===== Corporate ===== |
| | |
| | [[:Maximus]] is the provider of contact tracing services in the State of [[:United_States_of_America:New York]].((Foster, R. (2021, May 3). //Reston-based Maximus gets $951M contract for national COVID hotline.// Virginia Business. https://archive.ph/XGpdG)) |
| | |
| | ===== Guidelines ===== |
| |
| The WHO is still saying, in a 2019 paper called [[https://apps.who.int/iris/bitstream/handle/10665/329438/9789241516839-eng.pdf#page=9 | 'Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza']], that contact tracing is "not recommended in any circumstances" - and that applies to both an epidemic and a pandemic. | The WHO is still saying, in a 2019 paper called [[https://apps.who.int/iris/bitstream/handle/10665/329438/9789241516839-eng.pdf#page=9 | 'Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza']], that contact tracing is "not recommended in any circumstances" - and that applies to both an epidemic and a pandemic. |
